心房颤动导管消融:适应证与未来展望
本文综述了心房颤动(AF)导管消融的适应证、技术进展与未来方向。肺静脉隔离(PVI)仍是新诊断阵发性AF的独立消融策略,而非阵发性AF需联合后壁消融、非肺静脉触发灶消融等辅助策略;近期试验显示早期节律控制可预防心血管事件并延缓阵发性向持续性AF进展。
要点
- 肺静脉隔离是新诊断阵发性心房颤动的独立消融策略
- 非阵发性心房颤动单用PVI不足,需联合后壁及非肺静脉触发灶等辅助消融
- 早期节律控制可预防心血管事件并延缓阵发性向持续性心房颤动进展
核心结论
- 导管消融已成为心房颤动管理的基石,PVI是阵发性AF的标准消融策略,非阵发性AF需辅助消融策略,早期节律控制具有额外获益。
研究设计与样本
- 综述,总结心房颤动导管消融的适应证、技术进展与未来展望,未报告检索范围与样本量。
主要发现
- 肺静脉被首次描述为驱动AF的异位触发灶来源,由此确立PVI为治疗AF最广泛实施的术式。
- 环肺静脉前庭PVI仍被视为新诊断阵发性AF的独立消融策略。
- 在非阵发性AF患者中PVI似不充分,左房后壁及非肺静脉触发灶消融、AF标测与转子/驱动灶消融、Marshall静脉乙醇灌注及肾去神经等辅助策略结果不一。
- 近期试验记录到早期节律控制在延缓阵发性AF向更持续形式进展之外,还可预防心血管事件。
- 成功PVI后极晚期心律失常复发提示非肺静脉触发灶的关键作用及其作为再次手术潜在消融靶点的意义。
关键数值与推荐
- 环肺静脉前庭PVI为新诊断阵发性AF的独立消融策略;非阵发性AF需联合辅助消融策略;原文未报告具体数值与推荐等级。
临床怎么用
- 对新型阵发性AF以环肺静脉前庭PVI作为标准消融策略,非阵发性AF考虑联合后壁、非肺静脉触发灶等辅助消融,并重视早期节律控制。
局限性
- 为综述性文章,未报告系统检索策略、样本量及定量合并结果,各辅助消融策略结果不一。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Recent advances in techniques, technologies and proven superiority over anti-arrhythmic drugs have made catheter ablation the cornerstone of management for atrial fibrillation (AF), which has shown a steady increase in prevalence in the ageing population worldwide. The aim of therapeutic interventions is to achieve stable sinus rhythm that would improve the quality of life and reduce the risk of AF-associated complications. Pulmonary veins (PVs) were first described as the source of initiation of ectopic triggers driving AF, which led to the establishment of PV isolation (PVI) as the most widely practiced procedure to treat AF. Antral PVI is still recognized as the stand-alone ablation strategy for newly diagnosed paroxysmal AF (PAF). However, in non-PAF patients, PVI seems to be inadequate and several adjunctive strategies, including ablation of left atrial posterior wall and non-PV triggers, AF mapping and ablation of rotors and drivers, ethanol infusion of vein of Marshall and renal denervation, etc. have been reported with mixed results. Recent trials have also documented the benefits of early rhythm control in preventing cardiovascular events in addition to slowing the progression of PAF to more persistent forms. Similarly, very late relapse of the arrhythmia after successful PVI has drawn attention to the critical role of non-PV triggers and highlighted their relevance as potential ablation targets during repeat procedures. Ablation technology is also under constant evolution with the introduction of non-thermal energy sources and new tools to create durable lesions. This review summarizes the indications, advancements, and future perspective of AF ablation.
引用
- Natale A, Mohanty S, Sanders P, et al. Catheter ablation for atrial fibrillation: indications and future perspective. Eur Heart J. 2024. PMID: 39322413. doi:10.1093/eurheartj/ehae618
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。